Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pancreatic Insulin Production Capacity (PIPC) - a Feasibility Study
Sponsor: Ottawa Hospital Research Institute
Summary
The standard treatment for Type 2 diabetes involves management of the disease based on average of blood glucose control over the past few months. In this study, the investigators test for the participants' ability to produce insulin, which is the hormone that the body makes to control blood sugar levels. The body produces insulin in response to eating. The participants will drink a meal replacement shake, and then test the blood for levels of insulin produced over 2 hours. With blood tests taken five times over two hours, the investigators will measure the blood glucose (sugar), and insulin levels. This study will assess the differences in insulin produced in the participants and try to understand the reasons for these differences.
Official title: The Feasibility of an Innovative Protocol to Demonstrate the Impact of Positive Energy Balance on Pancreatic Insulin Production Capacity (PIPC)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2024-06-24
Completion Date
2025-09-30
Last Updated
2024-06-26
Healthy Volunteers
No
Conditions
Interventions
Boost Original meal replacement shake
One bottle of Boost Original meal replacement shake.
Locations (1)
The Ottawa Hospital
Ottawa, Ontario, Canada